Gut bugs linked to liver damage in new study
NCT ID NCT07313007
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how gut bacteria produce certain chemicals that might worsen fatty liver disease (MASLD). Researchers will collect stool, blood, and urine samples from 24 people with the condition and healthy volunteers. They aim to identify which bacteria are responsible for these harmful metabolites, which could lead to new treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could point toward new treatments for fatty liver disease by targeting gut bacteria.
- What could go wrong
- This is a small, early-stage observational study with only 24 participants, so results may not apply broadly and may not lead to treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier Lyon Sud Service Endocrinologie, Diabète et nutrition
RECRUITINGPierre-Bénite, 69495, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a common b vitamin tame fatty liver?
- Can Weight-Loss surgery beat drugs for advanced liver damage?
- Could a daily dose of citrus fiber tame fatty liver inflammation?
- Can a single gene therapy injection reverse fatty liver disease?
- Navy beans take on fatty liver: a diet swap put to the test
- Could a simple cooking tweak reverse fatty liver? a new trial puts low-AGE foods to the test.